Smurfit Kappa Group Investing Cash Flow decreased by 8.3% to -$627.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 31.7%, from -$476.00M to -$627.00M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a 28.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$255.00M | -$255.00M | -$255.00M | -$255.00M | $0.00 | $0.00 | -$677.00M | -$254.00M | -$207.00M | -$203.00M | -$1.19B | -$519.00M | -$476.00M | -$520.00M | -$568.00M | -$579.00M | -$627.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +100.0% | — | — | +62.5% | +18.5% | +1.9% | -483.7% | +56.2% | +8.3% | -9.2% | -9.2% | -1.9% | -8.3% |
| YoY Change | — | — | — | — | +100.0% | +100.0% | -165.5% | +0.4% | — | — | -75.0% | -104.3% | -130.0% | -156.2% | +52.1% | -11.6% | -31.7% |